Mangalam Drugs and Organics Share Price
20 Nov, 2026 3:51 PM (IST)
Mangalam Drugs and Organics Performance
- Today's Low
- ₹27
- Today's High
- ₹29
- 52 Week Low
- ₹23
- 52 Week High
- ₹54
- Open Price₹29
- Previous Close₹29
- Volume48,182
- 50 DMA₹29.70
- 100 DMA₹30.10
- 200 DMA₹34.30
Mangalam Drugs and Organics Chart
Investment Returns
- Over 1 Month -9.76%
- Over 3 Month + 2.23%
- Over 6 Month -10.44%
- Over 1 Year -43%
Smart Investing Starts Here Start SIP with Mangalam Drugs and Organics for Steady Growth!
Mangalam Drugs and Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -1.1
- PEG Ratio
- 0
- Market Cap Cr
- 44
- P/B Ratio
- 0.5
- Average True Range
- 1.6
- EPS
- -24.1
- Dividend Yield
- 0
- MACD Signal
- -0.5
- RSI
- 38.25
- MFI
- 31.2
Latest Stock News Updates
Disclosure pursuant to Regulation 30 LODR, 2025 for approval and consideration by Board of Directors at Meeting held on 18.11.2026 of the Company for undertaking of Financial Restructuring and exploring of various strategic options and convening of EGM to seek members approval to take fesiable action in the aforesaid matter.
- BSE India
- 3 days 9 hours ago
Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR, 2015 to consider and approve of financial restructuring , exploring strategic options and convening of EGM of the Company
- BSE India
- 3 days 10 hours ago
Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015
- BSE India
- 5 days 13 hours ago
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹29.20
- 50 Day
- ₹29.70
- 100 Day
- ₹30.10
- 200 Day
- ₹34.30
Resistance and Support
- R3 31.00
- R2 30.00
- R1 28.80
- S1 26.60
- S2 25.60
- S3 24.40
Mangalam Drugs and Organics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-05 | Quarterly Results | |
| 2026-08-12 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-03-26 | Others | Inter-alia, to consider 1. Taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer. 2. Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer. |
| 2026-02-06 | Others |
About Mangalam Drugs and Organics
Mangalam Drugs and Organics in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti-Malaria, Anti-Retrovirat, Anti-Hypertensive etc. It is the only API company globally to qualify under the Bill Clinton Foundation for supply of Anti-Malarial drugs and is amongst the 8 players globally (6 Formulators and 2 API players) with WHO prequalification for Anti-Malaria APIs- Artemether and Lumefantrine. View More- NSE Symbol
- MANGALAM
- BSE Symbol
- 532637
- ISIN
- INE584F01014
Similar Stocks to Mangalam Drugs and Organics
Popular Stocks
Mangalam Drugs and Organics FAQs
Mangalam Drugs and Organics share price is ₹27 As on 22 November, 2026 | 05:03
The Market Cap of Mangalam Drugs and Organics is ₹43.6 Cr As on 22 November, 2026 | 05:03
The P/E ratio of Mangalam Drugs and Organics is -1.1 As on 22 November, 2026 | 05:03
The PB ratio of Mangalam Drugs and Organics is 0.5 As on 22 November, 2026 | 05:03
The 52 week High & Low of Mangalam Drugs and Organics is ₹54.4/₹22.8 respectively As on 22 November, 2026 | 05:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.